Author: admin

Exhibiting antimicrobial resistance and ACTIVEIMMUNITY implication

EXHIBITING ANTIMICROBIAL RESISTANCE AND ACTIVEIMMUNITY IMPLICATION   INTERNATIONAL CONTEXT In April 30, 2014 World Health Organization (WHO) officially announced the end of the antibiotic era, at least of those existing at that time, following to make an exceptional effort to find and use effective potentiation of antibiotics and the use of new antimicrobial medicines. At […]

Immuno-VIP and Immuno-CIP: a support in the effort to treat the urinary tract infections with bacteria and superbugs resistant to antibiotics

Immuno-VIP and Immuno-CIP: a support in the effort to treat the urinary tract infections with bacteria and superbugs resistant to antibiotics The “superbug” Escherichia coli, multidrug resistant, including to the last-resort antibiotic colistin, showed up in China in 2015. The drug resistance gene known as mcr-1 – which has the capacity to move from one […]

Contribution of biologically active products, Immuno-VIP and Immuno-CIP as support for amelioration of psoriasis vulgaris symptoms

Contribution of biologically active products, Immuno-VIP and Immuno-CIP as support for amelioration of psoriasis vulgaris symptoms Psoriasis is by nature a chronic disease with an unpredictable course of symptoms and triggers, for which there is no cure. Psoriasis is a painful and disabling disease, which can affect the skin, nails and joints. This picture is […]